Skip to content
AwardedRomaniaGoodsRON 232,819

Reactivi de laborator si reactivi chimici -7 loturi in cadrul proiectului de cercetare PNRR 760067/23.05.2023, CF 81/15.11.2022, "Decoding the immuno-inflammatory axis in rare non-medullary thyroid cancer as an innovative approach for novel combinatory therapeutic approaches"

Published
Published 8 April 2026
Deadline
Closed 11 May 2026

Overview

The University of Medicine and Pharmacy

Key details

Country
Romania
Status
Awarded
Category
Goods
Estimated value
RON 232,819
Procedure
Open
Published
8 April 2026
Deadline
Closed
Classification (CPV)
Chemical reagentsLaboratory reagents

Award outcome

Awarded value
RON 202,136
Award date
22 June 2026
Contract period
— → 20 February 2000
Winners
  • ANTISEL RO SRL
  • DEXTER COM S.R.L.
  • MEDIST LIFE SCIENCE S.R.L.
  • Omnivet Impex S.R.L.
  • S.C. Bio Zyme S.R.L.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    24 June 2026

  2. Contract Notice

    9 April 2026

  3. Contract Notice

    8 April 2026

Contracting authority

  • Universitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca

    Procuring entity

    Cluj-Napoca, Romania

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Reactivi de laborator si reactivi chimici -7 loturi in cadrul proiectului de cercetare PNRR 760067/23.05.2023, CF 81/15.11.2022, "Decoding the immuno-inflammatory axis in rare non-medullary thyroid cancer as an innovative approach for novel combinatory therapeutic approaches" — won by ANTISEL RO SRL +4 — Skim